These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 5487661)

  • 1. Prognosis of the absolute configuration of the anticholinergic drug dextrobenzetimide.
    van Wijngaarden I; Soudyn W; van der Eycken C
    Life Sci I; 1970 Nov; 9(22):1289-302. PubMed ID: 5487661
    [No Abstract]   [Full Text] [Related]  

  • 2. The absolute configuration and crystal structure of the anticholinergic drug dexbenzetimide.
    Speck AL; Peerdeman AF; van Wijngaarden I; Soudijn W
    Nature; 1971 Aug; 232(5312):575-6. PubMed ID: 4937507
    [No Abstract]   [Full Text] [Related]  

  • 3. The structure of dihydroisohistrionicotoxin, a unique unstaurated alkaloid and anticholinergic agent.
    Karle IL
    J Am Chem Soc; 1973 Jun; 95(12):4036-40. PubMed ID: 4736278
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparison of the stereochemical requirements of cholinergic and anticholinergic drugs.
    Brimblecombe RW; Green D; Inch TD
    J Pharm Pharmacol; 1970 Dec; 22(12):951-3. PubMed ID: 4395525
    [No Abstract]   [Full Text] [Related]  

  • 5. Differential anticholinergic activity, metabolism and excretion of the optical isomers of 14C-benzetimide hydrochloride.
    van Wijngaarden I
    Life Sci; 1969 May; 8(9):517-23. PubMed ID: 5791704
    [No Abstract]   [Full Text] [Related]  

  • 6. [Theories on receptors and relations between structure and activity in the province of cholinergic and anticholinergic subsaances].
    Ariëns EJ
    Actual Pharmacol (Paris); 1969; 22():261-92. PubMed ID: 4396203
    [No Abstract]   [Full Text] [Related]  

  • 7. Anticholinergic agents based on Ariens' dual receptor site theory.
    Stubbins JF; Hudgins PM; Andrako J; Beebe AJ
    J Pharm Sci; 1968 Mar; 57(3):534-5. PubMed ID: 5655605
    [No Abstract]   [Full Text] [Related]  

  • 8. Modification of amphetamine effects by intracerebrally administered anticholinergic agents.
    Costall B; Naylor RJ
    Life Sci I; 1972 Mar; 11(5):239-53. PubMed ID: 4675889
    [No Abstract]   [Full Text] [Related]  

  • 9. MOLECULAR PHARMACOLOGICAL STUDIES ON DRUG-RECEPTOR COMPLEXES SYSTEM IN DRUG ACTION. IV. RELATIONSHIP BETWEEN ANTICHOLINERGIC AND ANTICHOLINESTERASE ACTIVITIES OF ORGANOPHOSPHORYL CHOLINE DERIVATIVES BASED ON THEIR CHEMICAL STRUCTURE.
    KIMURA M; SAIKAWA I
    Chem Pharm Bull (Tokyo); 1964 Feb; 12():159-65. PubMed ID: 14126744
    [No Abstract]   [Full Text] [Related]  

  • 10. Cholinergic and anticholinergic drugs, do they act on common receptors?
    Ariens EJ; Simonis AM
    Ann N Y Acad Sci; 1967 Oct; 144(2):842-69. PubMed ID: 5237271
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecular pharmacological studies on drug-receptor complexes system in drug action. VII. On anticholinergic activity of compounds containing 1,3-dioxolane moiety.
    Kimura M; Hirai S; Takai A
    Jpn J Pharmacol; 1968 Jun; 18(2):218-23. PubMed ID: 5303520
    [No Abstract]   [Full Text] [Related]  

  • 12. Structure-activity relations for anticholinergic dioxolans.
    Brimblecombe RW; Inch TD
    J Pharm Pharmacol; 1970 Dec; 22(12):881-8. PubMed ID: 4395509
    [No Abstract]   [Full Text] [Related]  

  • 13. Apparent correlations between pA2 and pD2' values in a group of drugs with antihistaminic and anticholinergic properties.
    van den Brink FG
    Br J Pharmacol; 1970 May; 39(1):220P-221P. PubMed ID: 4392963
    [No Abstract]   [Full Text] [Related]  

  • 14. Absolute configuration of 3-quinuclidinyl benzilate and the behavioral effect in the dog of the optical isomers.
    Meyerhöffer A
    J Med Chem; 1972 Sep; 15(9):994-5. PubMed ID: 5051020
    [No Abstract]   [Full Text] [Related]  

  • 15. 3-(aminoalkyl)-1,2,3,4-tetrahydro-5H-[1]benzopyrano[3,4-c] pyridin-5-ones as potential anticholinergic bronchodilators.
    Connor DT; Unangst PC; Schwender CF; Sorenson RJ; Carethers ME; Puchalski C; Brown RE; Finkel MP
    J Med Chem; 1989 Mar; 32(3):683-8. PubMed ID: 2645403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative correlations and reexamination of the importance of hydrophobic and steric factors in anticholinergic drug receptor interactions.
    Banerjee S; Lien EJ
    Pharm Res; 1990 Jul; 7(7):746-50. PubMed ID: 2395804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of some anticholinergic drugs on antidromic activity in the rat phrenic nerve-diaphragm preparation.
    Kojima M; Takagi H
    Eur J Pharmacol; 1969 Jan; 5(2):161-7. PubMed ID: 4305654
    [No Abstract]   [Full Text] [Related]  

  • 18. Anticholinergic side effects of tricyclic antidepressants and their management.
    Remick RA
    Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(2-3):225-31. PubMed ID: 3290996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nosological and prognostic distinctions in schizophrenia: pharmacological validation in terms of therapeutic antagonism between anticholinergic anti-parkinsonism drugs and neuroleptics.
    Singh MM; Kay SR
    Neuropsychobiology; 1978; 4(5):288-304. PubMed ID: 673165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of a new synthetic anticholinergic drug on gastric secretion].
    SALA E; MONTANI E
    Gazz Med Ital; 1959 May; 118(5):205-7. PubMed ID: 13664060
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.